Roberta Cappellari
Overview
Explore the profile of Roberta Cappellari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
824
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Albiero M, Migliozzi L, Boscaro C, Rodella A, Ciciliot S, Ivan Amendolagine F, et al.
Diabetes
. 2025 Feb;
PMID: 39945856
Microbial signals trigger the release of neutrophil extracellular traps (NETs) through peptidyl-arginine-deiminase-4 (PADI4). In turn, NETosis can propagate inflammation to distant tissues. We hypothesize that PADI4 mediates the interactions between...
2.
Bonora B, Marassi M, Fogar P, Zuin J, Cappellari R, Marinello S, et al.
Eur J Clin Invest
. 2023 Dec;
54(4):e14150.
PMID: 38088242
Background And Aims: An acute depletion of circulating haematopoietic stem/progenitor cells (HSPCs) occurs during COVID-19, especially among patients with a poorer disease course. We herein examined whether HSPCs levels at...
3.
Bonora B, Morieri M, Marassi M, Cappellari R, Avogaro A, Fadini G
Diabetologia
. 2023 Sep;
66(12):2346-2355.
PMID: 37712954
Aim/hypothesis: We examined whether prediction of long-term kidney outcomes in individuals with type 2 diabetes can be improved by measuring circulating levels of haematopoietic stem/progenitor cells (HSPCs), which are reduced...
4.
Dassie F, Albiero M, Bettini S, Cappellari R, Milan G, Ciciliot S, et al.
Endocrinology
. 2023 Jan;
164(3).
PMID: 36702623
Alström syndrome (AS) is a rare genetic disease caused by ALMS1 mutations, characterized by short stature, and vision and hearing loss. Patients with AS develop the metabolic syndrome, long-term organ...
5.
de Kreutzenberg S, Giannella A, Ceolotto G, Faggin E, Cappellari R, Mazzucato M, et al.
Diabetologia
. 2022 Jun;
65(9):1555-1568.
PMID: 35708762
Aims/hypothesis: Ectopic calcification is a typical feature of diabetic vascular disease and resembles an accelerated ageing phenotype. We previously found an excess of myeloid calcifying cells in diabetic individuals. We...
6.
Bonora B, Cappellari R, Grasso M, Mazzucato M, DAnna M, Avogaro A, et al.
Diabetes Ther
. 2022 Jun;
13(7):1327-1337.
PMID: 35676613
Background And Aim: Diabetes reduces the levels of circulating endothelial progenitor cells (EPCs), which contribute to vascular homeostasis. In turn, low EPCs levels predict progression of chronic complications. Several studies...
7.
Bonora B, Palano M, Testa G, Fadini G, Sangalli E, Madotto F, et al.
Aging Cell
. 2022 Feb;
21(3):e13545.
PMID: 35166014
Frailty affects the physical, cognitive, and social domains exposing older adults to an increased risk of cardiovascular disease and death. The mechanisms linking frailty and cardiovascular outcomes are mostly unknown....
8.
Bonora B, Fogar P, Zuin J, Falaguasta D, Cappellari R, Cattelan A, et al.
Diabetes
. 2022 Jan;
71(4):788-794.
PMID: 35061020
Admission hyperglycemia has emerged worldwide as a predictor of poor coronavirus disease 2019 (COVID-19) outcome. Hyperglycemia leads to a defect in circulating hematopoietic stem/progenitor cells (HSPCs), which, in turn, predicts...
9.
Bonora B, Albiero M, Morieri M, Cappellari R, Ivan Amendolagine F, Mazzucato M, et al.
Diabetologia
. 2021 Aug;
64(10):2334-2344.
PMID: 34368894
Aim/hypothesis: In two large RCTs, fenofibrate reduced the progression of diabetic retinopathy. We investigated whether fenofibrate increases circulating haematopoietic stem/progenitor cells (HSPCs), which have vascular properties and have been shown...
10.
Albiero M, Tedesco S, Ivan Amendolagine F, DAnna M, Migliozzi L, Zuccolotto G, et al.
Diabetes
. 2021 Apr;
70(8):1767-1779.
PMID: 33903150
The mechanisms by which sodium-glucose cotransporter 2 inhibitors (SGLT2i) improve cardiovascular outcomes in people with diabetes are incompletely understood. Recent studies show that SGLT2i may increase the levels of circulating...